Table 2.
Assay | CTX | PTX | CI | TTX | Refs |
---|---|---|---|---|---|
MBA | LODP-CTX-1 = 0.2 μg/kg SM LODC-CTX-1 = 3.0 μg/kg |
LD50 = 150–720 ng/µL | LOD13–desMeC = 5.6 μg/kg SM LODGYM A = 77 μg/kg SM. i.p. LD50PnTx E, F and G = 12.7–57 μg/kg SM |
LODTTX = 0.2 µg | [114,129,142,143,144,155,156,157,158] |
Citotoxicity assay | |||||
Haemolysis assays | LOD = 50 µg/mL | LOD = 1.6 ng/kg SM 0.005 pg/µL–1 pg/mL | - | LOD = 5.0 µg/mL | [73,74,146,159,160] |
Fluorimetric method | LOQC-CTX-1 = 0.039 ng/g | - | - | - | - |
Receptor-binding assays | LOQP-CTX-3Ceq = 15.5 fg/cul for algal samples 0.155 ng/g in fish samples | - | - | - | [161] |
RBA with Neuroblastoma | LOQC-CTX-1 = 0.039 ng/g | - | - | - | [162] |
Fluorescence polarization | |||||
Microsphere flow cytometry | - | - | LOQGYMA = 50–80 μg/kg LOQ13–desMeC = 50–85 μg/kg SM LOQ13,19–didesMeC = 40 μg/kg SM LOD13–desMeC = 10 μg/kg SM |
- | [163,164,165,166,167,168] |
Chemiluminescence method | - | - | LODSpirolides = 50 μg/kg SM | - | - |
Assays with MCF-7 cells | - | LOD = 0.5 ng/mL | - | - | [169] |
Assays with neuroblastoma cells | - | LOD = 5 ng/mL | - | LOD = 3.2–160 ng/mL | [145,170,171] |
Immunoassays | |||||
Immunobead assay (MIA) | LODP-CTX-1 = 32 ng/kg fish flesh | - | - | - | [147,172,173] |
CIEIA | - | - | - | LOD = 10 ng/mL | [149] |
ELISA | LOD = 0.28 ng/mL | LOD = 0.5 pg/mL | - | LOD = 5–50 ng/mL | [148,150,160,174,175] |
Surface plasmon resonance (SPR) | - | - | - | 100 µg/kg | [176] |
Chemical methods | |||||
HPLC-FLD/LC-FLD | LOD = 0.5–1.0 ng | LOD = 0.75 ng | - | LOD = 0.07 pmol–0.4 pmol | [73,177,178,179,180,181,182] |
HPLC/MS | LODP-CTX-1 = 4 ng/g | - | - | LOD = 2 ng/mL | [183,184] |
HPLC-UV/LC-UV | - | LOD = 0.1–2 μg | LODGYM = 5 ng/mL | LOD = 10 ng/mL | [185,186] |